Amanta Healthcare IPO is set to open next week on Monday, 1st September, 2025 and will close on 3rd September, 2025. It is a Mainboard IPO with an issue size of Rs. 126 crores. The allotment is set to be finalized by 3rd September, 2025. The IPO will tentatively be listing on BSE, NSE on 4th September, 2025.
The company aims to use the fundings for capital expenditure requirements and general corporate purposes.
Amanta Healthcare IPO Prospectus
Amanta Healthcare IPO Details
| IPO Date | 01-09-2025 to 03-09-2025 |
| Issue Type | Mainboard |
| Listing at | BSE, NSE |
| Issue Price Range | Rs. 120 to 126 per share |
| Face Value of each share | 10 |
| Lot Size | 119 |
| Total Issue Size | Rs. 126 crores |
| Sale Type | Fresh Capital |
| Fresh Issue | 1 crore shares |
| Tentative Allotment | 4th September, 2025 |
| Refund Initiation | 8th September, 2025 |
| Credit to Demat Account | 8th September, 2025 |
| Tentative Listing Date | 9th September, 2025 |
Price Band & Lot Size
The price for Amanta Healthcare IPO is set for Rs. 120 to 126 per share for a lot size of 119 shares. The minimum amount of investment required by investors based on the upper end:
- Retail investor: Rs. 14994
- Small Non-Individual Investor (14 lots): Rs. 2,09,926
- Big Non-Individual Investor (67 lots): Rs. 10,04, 598
Amanta Healthcare IPO Reservation
The exact details of reservation for Amanta Healthcare IPO shares are not known, however some estimates are online:
- For QIB: Not more than 50%
- For NII: Not less than 15%
- For RII: Not less than 35%
Lead Manager & Registrar
Beeline Capital Advisors Pvt. Ltd. and MUFG Intime India Pvt. Ltd. are the lead manager & registrar for Amanta Healthcare IPO issue respectively.
GMP of Amanta Healthcare IPO
As of 26 August,2025, the GMP for Amanta Healthcare IPO stand at Rs. 22 making the gain percentage to be around 17.46%.
Amanta Healthcare IPO Subscription Status
Amanta Healthcare IPO has been subscribed 82.61 times in total.
About Amanta Healthcare
Amanta Healthcare Ltd. was found in December 1994 by Mr. Bhavesh Patel. It is a pharmaceutical company involved in the development, manufacturing and marketing of sterile liquid products, mainly parenterals. They also are a contract manufacturing partner for various pharmaceuticals companies.
The company has over the years have developed their capabilities to become a versatile manufacturer of 0.5ml injectables to 1000 ml irrigation solutions.
Disclaimer: The information shared on this blog is collected from publicly available online sources and is intended for educational and informational purposes only. It should not be construed as financial, investment, or legal advice. Readers are encouraged to conduct their own research.